Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

SAH derived potent and selective EZH2 inhibitors

Journal Article · · Bioorganic and Medicinal Chemistry Letters
A series of novel enhancer of zeste homolog 2 (EZH2) inhibitors was designed based on the chemical structure of the histone methyltransferase (HMT) inhibitor SAH (S-adenosyl-l-homocysteine). These nucleoside-based EZH2 inhibitors blocked the methylation of nucleosomes at H3K27 in biochemical assays employing both WT PRC2 complex as well as a Y641N mutant PRC2 complex. The most potent compound, 27, displayed IC50’s against both complexes of 270 nM and 70 nM, respectively. To our knowledge, compound 27 is the most potent SAH-derived inhibitor of the EZH2 PRC2 complex yet identified. This compound also displayed improved potency, lipophilic efficiency (LipE), and selectivity profile against other lysine methyltransferases compared with SAH.
Research Organization:
Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)
Sponsoring Organization:
INDUSTRY
OSTI ID:
1405013
Journal Information:
Bioorganic and Medicinal Chemistry Letters, Journal Name: Bioorganic and Medicinal Chemistry Letters Journal Issue: 7 Vol. 25; ISSN 0960-894X
Publisher:
Elsevier
Country of Publication:
United States
Language:
ENGLISH

Similar Records

A partially disordered region connects gene repression and activation functions of EZH2
Journal Article · Sun Jul 05 20:00:00 EDT 2020 · Proceedings of the National Academy of Sciences of the United States of America · OSTI ID:1642238

An Evolutionarily Conserved Structural Platform for PRC2 Inhibition by a Class of Ezh2 Inhibitors
Journal Article · Wed Jun 13 20:00:00 EDT 2018 · Scientific Reports · OSTI ID:1511727

Dimerization of a Viral SET Protein Endows its Function
Journal Article · Fri Dec 30 23:00:00 EST 2011 · Proceedings of the National Academy of Sciences of the United States of America · OSTI ID:1041656